1Holmskov U, Thiel S, Jensenius JC. Collectins and fieolins:humoral lectins of the innate immune defense. Annu RevImmunol,2003, 21: 547 - 578.
2Lipscombe R J, Sumiya M, Hill AV,et al. High frequencies inAfrican and non - African populations of independent mutationsin the mannose binding protein gene. Hum Mol Genet, 1992,1:709 -715.
4Roos A, Garred P, Wildenberg ME,et al. Antibody -mediatedactiration of the classical pathway of complement may compensatefor mannose - binding lectin deficiency. Eur J Immunol, 2004,34 : 2589 - 2598.
5Bouwman LH, Roos A, Terpstra OT,et al. Mannose bindinglectin gene polymorphisms confer a major risk for severeinfections after liver transplantation. Gastroenterology,2005,129 : 408 - 414.
6Wyatt R J, Kanayama Y, Julian BA, et al. Complementactivation in IgA nephropathy. Kidney Int 1987 ; 31 : 1019 - 1023.
7Matsuda M, Shikata K, Wada J,et al. Deposition of mannanbinding protein and mannan binding protein - mediated complementactivation in the glomeruli of patients with IgA nephropathy. Nephron, 1998,80 : 408 -413.
8Lhotta K, Wurzner R, Konig P. Glomerular deposition of mannose - binding lectin in human glomerulonephritis. Nephrol Dial Transplant 1999; 14:881 -886.
9Endo M, Ohi H, Ohsawa I, et al. Glomerular deposition of mannose - binding lectin (MBL) indicates a novel mechanism of complement activation in IgA nephropathy. Nephrol Dial Transplant, 1998,13 : 1984 - 1990.
10Hisano S, Matsushita M, Fujita T,et al. Activation of the lectin complement pathway in Henoch - Schonlein purpura nephritis. Am J Kidney. Dis ,2005,45:295 -302.
2Jacobsen S, Madsen HO, Klarlund M, et al. The influence of mannose binding lectin polymorphisms on disease outcome in early polyarthritis. J Rheumatol, 2001, 28(5): 935-942.
3Steffensen R, Thiel S, Varming K, et al. Detection of structural gene mutations and promoter polymorphisms in the mannan-binding lectin (MBL) gene by polymerase chain reaction with sequence-specific primers. J Immunol Methods, 2000, 241(1-2): 33-42.
2Menzel S, Moeller MJ. Role of the podocyte in proteinuria. Ped- iatr Nephrol, 2011,26:1775-1780.
3Iehikawa I, Fogo A. Focal segmental glomerulosclerosis. Pedi- atric Nephrology, 1996,10: 374-391.
4Arias LF, Vieco BE, Arteta AA, et al. Expression oI nephrin, Podocin and a-actinin-4 in renal tissue ofpatients with protein-uria. Nefrologia, 2009,29: 569-575.
5Johnstone DB, Zhang J, George B, et al. Podocyte-speeific dele- tion of Myh9 encoding nonmuscle myosin heavy chain 2A pre- disposes mice to glomerulopathy. Molecular and cellular biolo- gy,2011,31:2162-2170.
6Hays T, DA'ati VD, Garellek JA, et al. Glomerular MYH9 ex- pression is reduced by HIV-1. AIDS,2012,26:797-803.
7Inoki K, Mori H, Wang J, et al. mTORC1 activation in podo- cytes is a critical step in the development of diabetic nephropa- thy in mice. The Journal of clinical investigation, 2011,121: 2181.
8Greka A,Mundel P. Balancing calcium signals through TRPC5 and TRPC6 in podocytes. Journal of the American Society of Nephrology, 2011,22 : 1969-1980.
9Wang L,Ellis MJ, Gomez JA, et al. Mechanisms of the protein- uria induced by Rho GTPases. Kidney International, 2012,81: 1075-1085.
10Vassiliadis J, Bracken C, Matthews D, et al. Calcium mediates glomerular filtration through calcineurin and mTORC2/Akt signaling. Journal of the American Society of Nephrology, 2011,22: 1453-1461.
